Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 327378

WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment


Phan, T. P.; Crane, C. H.; Janjan, N. A.; Vrdoljak, Eduard; Milas, L.; Mason, K. A.
WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment // International Journal of Pancreatology, 29 (2001), 1; 19-23 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 327378 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment

Autori
Phan, T. P. ; Crane, C. H. ; Janjan, N. A. ; Vrdoljak, Eduard ; Milas, L. ; Mason, K. A.

Izvornik
International Journal of Pancreatology (0169-4197) 29 (2001), 1; 19-23

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
gemcitabine; WR-2721; radiation demage; radioprotector; pancreatic cancer

Sažetak
Background: The nucleoside analog gemcitabine is a potent radiosensitizer of both tumor and normal mucosa, so severe toxic reactions have resulted from its combination with radiation in some clinical treatment schedules for pancreatic cancer. WR-2721 (amifostine) has been shown to reduce normal tissue toxicity produced from both radiation treatment and some chemotherapeutics. The aim of this study was to determine if WR-2721 can protect the gastrointestinal mucosa from injury by concurrent gemcitabine and radiation treatment. Methods and Materials: Gemcitabine was injected ip into C3Hf/Kam mice at a concentration of 33 mg/kg 24 h before whole-body irradiation. A single dose (200 mg/kg) of WR-2721 was given 30 min before the radiation treatment or 30 min before gemcitabine or at both times. A quantitative assessment of the chemotherapy/radiation-induced damage was carried out using the mouse microcolony assay for stem cell survival in the intestinal crypts. RESULTS: WR-2721 given 30 min before gemcitabine followed 24 h later by radiation did not confer any protection to the jejunum (DMF 0.95). However, WR-2721 administered 30 min before radiation without or with prior gemcitabine produced protection factors (PF) of 1.35 and 1.42 Conclusions: WR-2721 did not directly protect the gastrointestinal mucosa from gemcitabine toxicity, but it did protect the gemcitabine-radiosensitized mucosa from acute radiation damage by a factor of 1.42. Therefore, in clinical treatment protocols using concurrent chemoradiation with gemcitabine, WR-2721 may have clinical utility in protecting against radiation-induced mucosal toxicity.

Izvorni jezik
Engleski

Znanstvena područja
Biologija



POVEZANOST RADA


Profili:

Avatar Url Eduard Vrdoljak (autor)

Citiraj ovu publikaciju:

Phan, T. P.; Crane, C. H.; Janjan, N. A.; Vrdoljak, Eduard; Milas, L.; Mason, K. A.
WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment // International Journal of Pancreatology, 29 (2001), 1; 19-23 (međunarodna recenzija, članak, znanstveni)
Phan, T., Crane, C., Janjan, N., Vrdoljak, E., Milas, L. & Mason, K. (2001) WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment. International Journal of Pancreatology, 29 (1), 19-23.
@article{article, author = {Phan, T. P. and Crane, C. H. and Janjan, N. A. and Vrdoljak, Eduard and Milas, L. and Mason, K. A.}, year = {2001}, pages = {19-23}, keywords = {gemcitabine, WR-2721, radiation demage, radioprotector, pancreatic cancer}, journal = {International Journal of Pancreatology}, volume = {29}, number = {1}, issn = {0169-4197}, title = {WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment}, keyword = {gemcitabine, WR-2721, radiation demage, radioprotector, pancreatic cancer} }
@article{article, author = {Phan, T. P. and Crane, C. H. and Janjan, N. A. and Vrdoljak, Eduard and Milas, L. and Mason, K. A.}, year = {2001}, pages = {19-23}, keywords = {gemcitabine, WR-2721, radiation demage, radioprotector, pancreatic cancer}, journal = {International Journal of Pancreatology}, volume = {29}, number = {1}, issn = {0169-4197}, title = {WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment}, keyword = {gemcitabine, WR-2721, radiation demage, radioprotector, pancreatic cancer} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font